Abstract:Insulin-like growth factor binding protein-3 (IGFBP3) has been reported to be related to the risk of some cancers. Here we focussed on serum IGFBP3 as a possible biomarker of diagnosis and prognosis for oesophageal squamous carcinoma (ESCC). Enzyme-linked immunosorbent assay (ELISA) was used to measure the serum IGFBP3 level in the training cohort including 136 ESCC patients and 119 normal controls and the validation cohort with 55 ESCC patients and 42 normal controls. The receiver operating characteristics curve (ROC) was used to assess the diagnosis value. Cox proportional hazards model was applied to select factors for survival nomogram construction. Serum IGFBP3 levels were significantly lower in early-stage ESCC or ESCC patients than those in normal controls ( p < .05). The specificity and sensitivity of serum IGFBP3 for the diagnosis of ESCC were 95.80% and 50.00%, respectively, with the area under the ROC curve (AUC) of 0.788 in the training cohort. Similar results were observed in the validation cohort (88.10%, 38.18%, and 0.710). Importantly, serum IGFBP3 could also differentiate early-stage ESCC from controls (95.80%, 52.54%, 0.777 and 88.10%, 36.36%, 0.695 in training and validation cohorts, respectively). Furthermore, Cox multivariate analysis revealed that serum IGFBP3 was an independent prognostic risk factor (HR = 2.599, p = .002). Lower serum IGFBP3 level was correlated with reduced overall survival ( p < .05). Nomogram based on serum IGFBP3, TNM stage, and tumour size improved the prognostic prediction of ESCC with a concordance index of 0.715. We demonstrated that serum IGFBP3 was a potential biomarker of diagnosis and prognosis for ESCC. Meanwhile, the nomogram might help predict the prognosis of ESCC. Serum IGFBP3 showed early diagnostic value in oesophageal squamous cell carcinoma with independent cohort validation. Moreover, serum IGFBP3 was identified as an independent prognostic risk factor, which was used to construct a nomogram with improved prognosis ability in oesophageal squamous cell carcinoma.

Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma

Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma

Xrcc3 is A Promising Target to Improve the Radiotherapy Effect of Esophageal Squamous Cell Carcinoma

The Overexpression of IGFBP-3 is Involved in the Chemosensitivity of Esophageal Squamous Cell Carcinoma Cells to Nimotuzumab Combined with Cisplatin

Effects of Insulin-Like Growth Factor Binding Protein 3 on Cell Growth and Tumorigenesis in Oral Squamous Cell Carcinoma

PI3Kα Inhibitors Sensitize Esophageal Squamous Cell Carcinoma to Radiation by Abrogating Survival Signals in Tumor Cells and Tumor Microenvironment.

Assessment Of Insulin-Like Growth Factor 1 Receptor As An Oncogene In Esophageal Squamous Cell Carcinoma And Its Potential Implication In Chemotherapy

Polymorphisms of Insulin-Like Growth Factor Binding Protein-3 As a Predictor for Risk and Patient Survival in Esophageal Squamous Cell Carcinoma

Nimotuzumab Promotes Radiosensitivity of EGFR-overexpression Esophageal Squamous Cell Carcinoma Cells by Upregulating IGFBP-3

Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma

Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma

PIG3 downregulation enhances the radio sensitivity of NSCLC cells by promoting G2/M cell cycle arrest and apoptosis

Insulin‑like Growth Factor‑1 Receptor Knockdown Enhances Radiosensitivity Via the HIF‑1α Pathway and Attenuates ATM/H2AX/53BP1 DNA Repair Activation in Human Lung Squamous Carcinoma Cells

Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.

Effects and Underlying Mechanisms of Homologous Recombina-Tion-associated Protein XRCC3 on Esophageal Squamous-Cell Carci-Noma Radiotherapy Response

NRIP3 Upregulation Confers Resistance to Chemoradiotherapy in ESCC Via RTF2 Removal by Accelerating Ubiquitination and Degradation of RTF2

Adaptive EGF Expression Sensitizes Pancreatic Cancer Cells to Ionizing Radiation Through Activation of the Cyclin D1/P53/PARP Pathway

Expression Profile, Clinical Significance and Biological Functions of IGF2BP2 in Esophageal Squamous Cell Carcinoma.

Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors

Overexpression of insulin-like growth factor binding protein 3 in oral squamous cell carcinoma.